Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Biotechnology industry in Boston - Wikipedia

   en.wikipedia.org/wiki/Biotechnology_industry_in...

   While Greater Boston area biotechnology companies began announcing layoffs of 30 to 60% of company workforces (with some firms shutting down altogether) as the 2022 stock market decline began, [20] [21] the Greater Boston biotechnology industry workforce continued to grow from approximately 84,000 in 2020 to 114,000 in 2022. [22]

3. BioNTech - Wikipedia

   en.wikipedia.org/wiki/BioNTech

   Biontech FY 2023 report [ 1] BioNTech SE ( / biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[ 2] short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.

4. Boston Scientific - Wikipedia

   en.wikipedia.org/wiki/Boston_Scientific

   Boston Scientific was formed June 29, 1979, in Watertown, Massachusetts, as a holding company for the medical products company, Medi-Tech, Inc., and to position the company for growth in interventional medicine. [ 6] Medi-Tech was the brainchild of Itzhak Bentov, a Czech-born émigré to Israel and then to the United States, who worked at the ...

5. Edward M. Kennedy Academy for Health Careers - Wikipedia

   en.wikipedia.org/wiki/Edward_M._Kennedy_Academy...

   The Edward M. Kennedy Academy for Health Careers (formerly Health Careers Academy) is one of several Horace Mann Charter Schools in the Boston Public Schools system. [2] On April 25, 2010, the school was renamed to honor the late senator, Edward M. Kennedy . Located in Boston, Massachusetts, United States on the campus of Northeastern ...

6. AOL Mail

   mail.aol.com

   You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.

7. BioNTech's cancer drug meets primary endpoint in Phase 2 trial

   www.aol.com/news/biontechs-cancer-drug-meets...

   (Reuters) - COVID-19 vaccine maker BioNTech's cancer drug candidate BNT111 showed significant improvement in the response rate in patients with advanced melanoma during a Phase 2 trial, the German ...